[Effect of chlorfibrinic acid on the triglyceride and glycogen contents of human liver as well as on blood-level forming metabolites].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D002994:Clofibrate / Q000627:therapeutic use*; D005234:Fatty Liver / Q000188:drug therapy*; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008099:Liver / Q000378:metabolism; D008134:Long-Term Care; D008875:Middle Aged; D014280:Triglycerides / Q000378:metabolism
D001786:Blood Glucose; D008055:Lipids; D014280:Triglycerides; D006003:Glycogen; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D002994:Clofibrate
Untersuchungen zur Wirkung von Chlorfibrinsäure auf den Triglyzerid- und Glykogengehalt der menschlichen Leber sowie blutspiegelbildende Metaboliten.